219 related articles for article (PubMed ID: 28428725)
1. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma.
Rimassa L; Reig M; Abbadessa G; Peck-Radosavljevic M; Harris W; Zagonel V; Pastorelli D; Rota Caremoli E; Porta C; Damjanov N; Patel H; Daniele B; Lamar M; Schwartz B; Goldberg T; Santoro A; Bruix J
World J Gastroenterol; 2017 Apr; 23(13):2448-2452. PubMed ID: 28428725
[TBL] [Abstract][Full Text] [Related]
2. Challenges of advanced hepatocellular carcinoma.
Colagrande S; Inghilesi AL; Aburas S; Taliani GG; Nardi C; Marra F
World J Gastroenterol; 2016 Sep; 22(34):7645-59. PubMed ID: 27678348
[TBL] [Abstract][Full Text] [Related]
3. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
Rastogi A
World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
Memon K; Kulik L; Lewandowski RJ; Gupta R; Ryu RK; Miller FH; Vouche M; Atassi R; Ganger D; Mulcahy MF; Salem R
J Vasc Interv Radiol; 2013 Aug; 24(8):1189-1197.e2. PubMed ID: 23474327
[TBL] [Abstract][Full Text] [Related]
5. Considerations of heterogeneity in clinical trials for hepatocellular carcinoma.
Liu TH; Shao YY; Lu LC; Shen YC; Hsu C; Lin ZZ; Hsu CH; Cheng AL
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):615-621. PubMed ID: 31132887
[No Abstract] [Full Text] [Related]
6. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
8. Developments in predictive biomarkers for hepatocellular carcinoma therapy.
Casadei-Gardini A; Orsi G; Caputo F; Ercolani G
Expert Rev Anticancer Ther; 2020 Jan; 20(1):63-74. PubMed ID: 31910040
[No Abstract] [Full Text] [Related]
9. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Kis B; El-Haddad G; Sheth RA; Parikh NS; Ganguli S; Shyn PB; Choi J; Brown KT
Cancer Control; 2017; 24(3):1073274817729244. PubMed ID: 28975829
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
[TBL] [Abstract][Full Text] [Related]
11. A multidisciplinary approach: group dynamics.
Taddei TH
J Clin Gastroenterol; 2013 Jul; 47 Suppl():S27-9. PubMed ID: 23632364
[TBL] [Abstract][Full Text] [Related]
12. Updated treatment approach to hepatocellular carcinoma.
Llovet JM
J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
[TBL] [Abstract][Full Text] [Related]
13. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G;
Trials; 2014 Dec; 15():474. PubMed ID: 25472660
[TBL] [Abstract][Full Text] [Related]
14. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.
Lehrich BM; Zhang J; Monga SP; Dhanasekaran R
J Hepatol; 2024 Mar; 80(3):515-530. PubMed ID: 38104635
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma.
Venook AP
Curr Treat Options Oncol; 2000 Dec; 1(5):407-15. PubMed ID: 12057148
[TBL] [Abstract][Full Text] [Related]
16. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
Fu Y; Liu S; Zeng S; Shen H
J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
[TBL] [Abstract][Full Text] [Related]
17. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes.
Iñarrairaegui M; Melero I; Sangro B
Clin Cancer Res; 2018 Apr; 24(7):1518-1524. PubMed ID: 29138342
[TBL] [Abstract][Full Text] [Related]
19. Medical Management of Hepatocellular Carcinoma.
Rich NE; Yopp AC; Singal AG
J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]